Lead Identification & Optimization topic: Early immunogenicity risk assessment and functional testing of traditional and complex biotherapeutics
22 Sep 2025
Formats & Scaffolds
- In silico and in vitro immunogenicity assessment as a de-risking strategy
- Approaches to mitigate the unwanted immunogenicity of therapeutic proteins
- Designing low immunogenic antibodies
- In vitro Functional testing of lead candidates
